Wall Street brokerages expect Caretrust REIT Inc (NASDAQ:CTRE) to report $44.94 million in sales for the current quarter, according to Zacks. Three analysts have issued estimates for Caretrust REIT’s earnings. The lowest sales estimate is $43.92 million and the highest is $46.40 million. Caretrust REIT posted sales of $39.51 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 13.7%. The business is expected to report its next earnings results on Monday, November 4th.

On average, analysts expect that Caretrust REIT will report full year sales of $175.22 million for the current fiscal year, with estimates ranging from $170.89 million to $179.00 million. For the next year, analysts anticipate that the firm will post sales of $191.06 million, with estimates ranging from $179.91 million to $204.10 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that follow Caretrust REIT.

Caretrust REIT (NASDAQ:CTRE) last released its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.35 by ($0.14). Caretrust REIT had a net margin of 39.70% and a return on equity of 8.08%. The business had revenue of $46.20 million for the quarter, compared to analysts’ expectations of $43.23 million. During the same period in the previous year, the company earned $0.33 EPS. Caretrust REIT’s revenue for the quarter was up 18.6% compared to the same quarter last year.

A number of research analysts have weighed in on the stock. Raymond James cut shares of Caretrust REIT from a “strong-buy” rating to a “market perform” rating and set a $25.00 price objective on the stock. in a research report on Friday, May 31st. BidaskClub upgraded shares of Caretrust REIT from a “sell” rating to a “hold” rating in a research report on Tuesday, August 6th. Zacks Investment Research cut shares of Caretrust REIT from a “hold” rating to a “strong sell” rating in a research report on Monday. Stifel Nicolaus set a $26.00 price objective on shares of Caretrust REIT and gave the company a “buy” rating in a research report on Wednesday, May 8th. Finally, ValuEngine cut shares of Caretrust REIT from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $23.86.

CTRE stock traded up $0.04 during mid-day trading on Thursday, reaching $23.46. 652,900 shares of the stock traded hands, compared to its average volume of 923,203. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.97 and a current ratio of 0.97. Caretrust REIT has a one year low of $16.68 and a one year high of $25.54. The stock has a market capitalization of $2.24 billion, a PE ratio of 18.33 and a beta of 0.74. The business has a 50-day moving average price of $23.45 and a two-hundred day moving average price of $23.63.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Royal Bank of Canada grew its holdings in shares of Caretrust REIT by 105.5% in the second quarter. Royal Bank of Canada now owns 32,283 shares of the real estate investment trust’s stock worth $768,000 after purchasing an additional 16,573 shares during the last quarter. Amundi Pioneer Asset Management Inc. grew its holdings in shares of Caretrust REIT by 8.9% in the second quarter. Amundi Pioneer Asset Management Inc. now owns 189,138 shares of the real estate investment trust’s stock worth $4,498,000 after purchasing an additional 15,419 shares during the last quarter. United Services Automobile Association grew its holdings in shares of Caretrust REIT by 3.7% in the second quarter. United Services Automobile Association now owns 209,575 shares of the real estate investment trust’s stock worth $4,984,000 after purchasing an additional 7,466 shares during the last quarter. Nuveen Asset Management LLC grew its holdings in shares of Caretrust REIT by 814.2% in the second quarter. Nuveen Asset Management LLC now owns 1,666,726 shares of the real estate investment trust’s stock worth $39,635,000 after purchasing an additional 1,484,408 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of Caretrust REIT by 12.2% in the second quarter. Price T Rowe Associates Inc. MD now owns 62,351 shares of the real estate investment trust’s stock worth $1,483,000 after purchasing an additional 6,777 shares during the last quarter. Hedge funds and other institutional investors own 84.14% of the company’s stock.

About Caretrust REIT

CareTrust REIT, Inc is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 199 net-leased healthcare properties and three operated seniors housing properties in 27 states, CareTrust is pursuing opportunities across the nation to acquire properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses.

Featured Article: Google Finance Portfolio

Get a free copy of the Zacks research report on Caretrust REIT (CTRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Caretrust REIT (NASDAQ:CTRE)

Receive News & Ratings for Caretrust REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caretrust REIT and related companies with MarketBeat.com's FREE daily email newsletter.